These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6271820)

  • 1. Clinical relevance of cannabis tolerance and dependence.
    Jones RT; Benowitz NL; Herning RI
    J Clin Pharmacol; 1981; 21(S1):143S-152S. PubMed ID: 6271820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical studies of cannabis tolerance and dependence.
    Jones RT; Benowitz N; Bachman J
    Ann N Y Acad Sci; 1976; 282():221-39. PubMed ID: 798533
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspects of tolerance to and dependence on cannabis.
    Wikler A
    Ann N Y Acad Sci; 1976; 282():126-47. PubMed ID: 828472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis and the development of tolerance.
    Hollister LE
    Adv Biosci; 1978 Jul 22-23; 22-23():585-9. PubMed ID: 756845
    [No Abstract]   [Full Text] [Related]  

  • 5. Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.
    Allsop DJ; Copeland J; Lintzeris N; Dunlop AJ; Montebello M; Sadler C; Rivas GR; Holland RM; Muhleisen P; Norberg MM; Booth J; McGregor IS
    JAMA Psychiatry; 2014 Mar; 71(3):281-91. PubMed ID: 24430917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cannabis withdrawal syndrome in patients with cannabis dependence only, and in patients with cannabis and opioid dependence].
    Vorspan F; Guillem E; Bloch V; Bellais L; Sicot R; Noble F; Lepine JP; Gorelick DA
    Encephale; 2011 Sep; 37(4):266-72. PubMed ID: 21981886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration.
    Schlienz NJ; Lee DC; Stitzer ML; Vandrey R
    Drug Alcohol Depend; 2018 Jun; 187():254-260. PubMed ID: 29689485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.
    Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
    Psychopharmacology (Berl); 2016 Jul; 233(13):2469-78. PubMed ID: 27085870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acute and chronic inhalation of hashish, marijuana, and delta 9-tetrahydrocannabinol on brain electrical activity in man: evidence for tissue tolerance.
    Fink M
    Ann N Y Acad Sci; 1976; 282():387-98. PubMed ID: 1071390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marijuana dependence: not just smoke and mirrors.
    Ramesh D; Schlosburg JE; Wiebelhaus JM; Lichtman AH
    ILAR J; 2011; 52(3):295-308. PubMed ID: 23382144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abstinence symptoms following oral THC administration to humans.
    Haney M; Ward AS; Comer SD; Foltin RW; Fischman MW
    Psychopharmacology (Berl); 1999 Feb; 141(4):385-94. PubMed ID: 10090646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marijuana withdrawal in humans: effects of oral THC or divalproex.
    Haney M; Hart CL; Vosburg SK; Nasser J; Bennett A; Zubaran C; Foltin RW
    Neuropsychopharmacology; 2004 Jan; 29(1):158-70. PubMed ID: 14560320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of zopiclone physical dependence liability in normal volunteers.
    Dorian P; Sellers EM; Kaplan H; Hamilton C
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():228-34. PubMed ID: 7188376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabbit behavioral model of marijuana psychoactivity in humans.
    Consroe P; Fish BS
    Med Hypotheses; 1981 Aug; 7(8):1079-90. PubMed ID: 6270517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nabilone therapy for cannabis withdrawal presenting as protracted nausea and vomiting.
    Lam PW; Frost DW
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25246463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal phenomena and dependence syndrome after the consumption of "spice gold".
    Zimmermann US; Winkelmann PR; Pilhatsch M; Nees JA; Spanagel R; Schulz K
    Dtsch Arztebl Int; 2009 Jul; 106(27):464-7. PubMed ID: 19652769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of cannabinoids (delta9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction.
    Dhawan K; Kumar S; Sharma A
    J Pharm Pharmacol; 2002 Jun; 54(6):875-81. PubMed ID: 12079005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of gonadal hormones on cannabinoid dependence.
    Marusich JA; Craft RM; Lefever TW; Wiley JL
    Exp Clin Psychopharmacol; 2015 Aug; 23(4):206-16. PubMed ID: 26237318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of cannabinoids.
    Grotenhermen F
    Clin Pharmacokinet; 2003; 42(4):327-60. PubMed ID: 12648025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns.
    Feinberg I; Jones R; Walker J; Cavness C; Floyd T
    Clin Pharmacol Ther; 1976 Jun; 19(6):782-94. PubMed ID: 178475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.